A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer (Q48126437)
Jump to navigation
Jump to search
scientific article published on 28 January 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer |
scientific article published on 28 January 2015 |
Statements
1 reference
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer (English)
1 reference
J S Chen
1 reference
C Hsu
1 reference
N J Chiang
1 reference
C S Tsai
1 reference
H H Tsou
1 reference
S F Huang
1 reference
L Y Bai
1 reference
I C Chang
1 reference
H S Shiah
1 reference
C L Ho
1 reference
C J Yen
1 reference
K D Lee
1 reference
C F Chiu
1 reference
K M Rau
1 reference
M S Yu
1 reference
Y Yang
1 reference
R K Hsieh
1 reference
J Y Chang
1 reference
Y S Shan
1 reference
Y Chao
1 reference
L T Chen
1 reference
Taiwan Cooperative Oncology Group
1 reference
28 January 2015
1 reference
26
1 reference
5
1 reference
943-949
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference